SRPT

Sarepta Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$23.23

Market Cap

$2.44B

Beta

0.28

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+15.58%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+33.06%

P/E Ratio0.0

PEG Ratio—

FCF Yield-13.02%

Debt / Equity0.91

Interest Coverage-28.1x

No credit card required

Already have an account? Sign in to view the full analysis for SRPT.